欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SK/H/0220/001
药品名称Dexamethasone hameln 4 mg/ml solution for injection
活性成分
    • Dexamethasone sodium phosphate 4.0 mg/ml
剂型Solution for injection
上市许可持有人hameln pharma gmbh, Inselstraße 1, 31787 Hameln, Germany
参考成员国 - 产品名称Slovakia (SK)
Dexamethasone hameln 4 mg/ml injekčný roztok
互认成员国 - 产品名称
    • Iceland (IS)
    • Belgium (BE)
      Dexamethason hameln 4 mg/ml solution injectable
    • Romania (RO)
      Dexametazonă S.MED 4 mg/ml soluţie injectabilă
    • Netherlands (NL)
      Dexamethasone S.MED 4 mg/ml oplossing voor injectie
    • Slovenia (SI)
    • Ireland (IE)
    • Croatia (HR)
      Deksametazon hameln 4 mg/ml otopina za injekciju
    • Austria (AT)
    • Portugal (PT)
    • Italy (IT)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Dexamethasone S.MED
    • Hungary (HU)
    • Germany (DE)
      Dexamethasone S.MED 4 mg/ml Injektionslösung
    • Bulgaria (BG)
      Dexamethasone S.MED
    • Denmark (DK)
许可日期2021/04/28
最近更新日期2025/01/29
药物ATC编码
    • H02AB02 dexamethasone
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase